<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Health-related quality of life is decreased in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> and <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVE: To determine whether time-tradeoff (TTO) values would differ in patients with BE when patients were asked to trade away the potential risk of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> rather than <z:hpo ids='HP_0011010'>chronic</z:hpo> heartburn symptoms </plain></SENT>
<SENT sid="2" pm="."><plain>DESIGN: A prospective clinical trial </plain></SENT>
<SENT sid="3" pm="."><plain>PATIENTS: Subjects with biopsy-proven BE </plain></SENT>
<SENT sid="4" pm="."><plain>INTERVENTIONS: Custom-designed computer program to elicit health-state utility values, quality of life in reflux and <z:e sem="disease" ids="C0013395" disease_type="Disease or Syndrome" abbrv="">dyspepsia</z:e> (QOLRAD), and Medical Outcomes Survey short form-36 surveys </plain></SENT>
<SENT sid="5" pm="."><plain>MAIN OUTCOME MEASUREMENTS: TTO utility values for the annual <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-risk-associated current health state and for hypothetical scenarios of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: We studied 60 patients in the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-risk cohort (57 men, 92% veteran; mean age [standard deviation; SD], 65 years [11 years], mean <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> duration 17 years [12 years]) </plain></SENT>
<SENT sid="7" pm="."><plain>The heartburn cohort included 40 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> and BE with TTO values derived for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> symptoms </plain></SENT>
<SENT sid="8" pm="."><plain>The mean (SD) utility for nondysplastic BE was 0.91 (0.13) compared with 0.90 (0.12) for the heartburn cohort (P = .7) </plain></SENT>
<SENT sid="9" pm="."><plain>The mean utility values were significantly lower for scenarios of low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (0.85 [0.12], P = .02) and high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (0.77 [0.14], P &lt; .005) </plain></SENT>
<SENT sid="10" pm="."><plain>The mean TTO was 0.67 (0.19) for the scenario of <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>There was no correlation between the utility scores and the disease-specific survey scores </plain></SENT>
<SENT sid="12" pm="."><plain>LIMITATIONS: TTO values were hypothetical for states of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: TTO utility values based on heartburn symptoms or annual risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in patients with nondysplastic BE are roughly equivalent </plain></SENT>
<SENT sid="14" pm="."><plain>However, TTO utility values are significantly lower for health states with increasing <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risks </plain></SENT>
</text></document>